Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome

Fertility and Sterility

Volumn 96, Issue 1, 2011, Pages 246-250

  Yildizhan, Recep ^a   Ilhan, Gokce Anik ^b   Yildizhan, Begum ^b   Kolusari, Ali ^a   Adali, Ertan ^a   Bugdayci, Guler ^c  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

ADMA; insulin resistance (HOMA IR); leptin; nonobese; obese; PCOS; RBP4

Indexed keywords

ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; N(G),N(G) DIMETHYLARGININE; PRASTERONE SULFATE; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADULT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OBESITY; OVARY POLYCYSTIC DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; ARGININE; BIOLOGICAL MARKERS; FEMALE; HUMANS; LEPTIN; OBESITY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; RETINOL-BINDING PROTEINS, PLASMA; YOUNG ADULT;

EID: 79959869560     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.04.073     Document Type: Article

References (34)

1. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853 861
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
3. F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, S. Di Biase, and T. Russo Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 4588 4593 (Pubitemid 39244474)
4. F. Orio, L. Vuolo, S. Palomba, G. Lombardi, and A. Colao Metabolic and cardiovascular consequences of polycystic ovary syndrome Minerva Ginecol 60 2008 39 51 (Pubitemid 351517721)
5. E.O. Talbott, D.S. Guzick, K. Sutton-Tyrrell, K.P. McHugh-Pemu, J.V. Zborowski, and K.E. Remsberg Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women Arterioscler Thromb Vasc Biol 20 2000 2414 2421
6. F. Giallauria, F. Orio, S. Palomba, G. Lombardi, A. Colao, and C. Vigorito Cardiovascular risk in women with polycystic ovary syndrome J Cardiovasc Med 9 2008 987 992
7. F. Ovalle, and R. Aziz Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus Fertil Steril 77 2002 1095 1105 (Pubitemid 34626313)
8. L. Speroff, and M.A. Fritz Obesity. The physiology of adipose tissue, and the problem of obesity L. Speroff, M.A. Fritz, Clinical gynecologic endocrinology and infertility 2005 Lippincott Williams & Wilkins Philadelphia 779 804
9. J.D. Knudson, U.D. Dincer, C. Zhang, A.N. Swafford Jr., R. Koshida, and A. Picchi Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction Am J Physiol Heart Circ Physiol 289 2005 H48 H56
10. M.P. Reilly, N. Iqbal, M. Schutta, M.L. Wolfe, M. Scally, and A.R. Localio Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J Clin Endocrinol Metab 89 2004 3872 3878 (Pubitemid 39071487)
11. V.P. Sepilian, J.R. Crochet, and M. Nagamani Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens Fertil Steril 85 2006 1441 1447
12. B. Pehlivanov, and M. Mitkov Serum leptin levels correlate with clinical andbiochemical indices of insulin resistance in women with polycystic ovarysyndrome Eur J Contracept Reprod Health Care 14 2009 153 159
13. V.P. Valkonen, H. Päivä, J.T. Salonen, T.A. Lakka, T. Lehtimäki, and J. Laakso Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 358 2001 2127 2128 (Pubitemid 34094905)
14. T.K. Krempl, R. Maas, K. Sydow, T. Meinertz, R.H. Böger, and J. Kähler Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events Eur Heart J 26 2005 1846 1851 (Pubitemid 41253296)
15. Q. Yang, T.E. Graham, N. Mody, F. Preitner, O.D. Peroni, and J.M. Zabolotny Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 436 2005 356 362 (Pubitemid 41065039)
16. T.E. Graham, Q. Yang, M. Blüher, A. Hammarstedt, T.P. Ciaraldi, and R.R. Henry Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects N Engl J Med 354 2006 2552 2563 (Pubitemid 43882351)
17. D.C. Lee, J.W. Lee, and J.A. Im Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents Metabolism 56 2007 327 331
18. R. Hatch, R.L. Rosenfield, M.H. Kim, and D. Tredway Hirsutism: implications, etiology, and management Am J Obstet Gynecol 140 1981 815 830 (Pubitemid 11046650)
19. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
20. K.E. Remsberg, E.O. Talbott, J.V. Zborowski, R.W. Evans, and K. McHugh-Pemu Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome Fertil Steril 78 2002 479 486
21. H. El Orabi, A.A. Ghalia, A. Khalifa, H. Mahfouz, A. El Shalkani, and N. Shoieb Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome Clin Biochem 32 1999 71 75 (Pubitemid 29095769)
22. R.C. Christian, D.A. Dumesic, T. Behrenbeck, A.L. Oberg, P.F. Sheedy 2nd, and L.A. Fitzpatrick Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 2562 2568 (Pubitemid 36724424)
23. F. Demirel, A. Bideci, P. Cinaz, M.O. Camurdan, G. Biberolu, and E. Yesilkaya Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome Clin Endocrinol (Oxf) 67 2007 129 134 (Pubitemid 46955452)
24. K. Berneis, M. Rizzo, M. Hersberger, G.B. Rini, G. Di Fede, and I. Pepe Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome Int J Clin Pract 63 2009 56 62
25. R.A. DeFronzo, and E. Ferrannini Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173 194
26. D. Heutling, H. Schulz, I. Nickel, J. Kleinstein, P. Kaltwasser, and S. Westphal Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment J Clin Endocrinol Metab 93 2008 82 90
27. K. Krzyzanowska, F. Mittermayer, H.P. Kopp, M. Wolzt, and G. Schernthaner Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women J Clin Endocrinol Metab 89 2004 6277 6281 (Pubitemid 39628445)
28. T. Ozgurtas, C. Oktenli, M. Dede, S. Tapan, L. Kenar, and S.Y. Sanisoglu Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS) Atherosclerosis 200 2008 336 344
29. M. Landay, A. Huang, and R. Azziz Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS Fertil Steril 92 2009 643 647
30. A. Atamer, N. Ilhan, Y. Kocyigit, G. Toprak, M. Ozbay, and Y. Celik The role of asymmetric dimethylarginine (ADMA) and leptin in hypertensive patients J Int Med Res 36 2008 54 62 (Pubitemid 351255970)
31. S. Hahn, M. Backhaus, M. Broecker-Preuss, S. Tan, T. Dietz, and R. Kimmig Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism Eur J Endocrinol 157 2007 201 207 (Pubitemid 47233125)
32. S.K. Hutchison, C. Harrison, N. Stepto, C. Meyer, and H.J. Teede Retinol-binding protein4 and insulin resistance in polycystic ovary syndrome Diabetes Care 31 2008 1427 1432
33. M. Möhlig, M.O. Weickert, E. Ghadamgahi, A.M. Arafat, J. Spranger, and A.F. Pfeiffer Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome Eur J Endocrinol 158 2008 517 523 (Pubitemid 351606347)
34. T.F. Chan, Y.C. Tsai, P.R. Chiu, Y.L. Chen, C.H. Lee, and E.M. Tsai Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome Fertil Steril 93 2010 869 873